068760.KQ Celltrion Pharm, Inc.
KOEHealthcareAs of 2026-08-09 03:26
Why 068760.KQ matters now
Celltrion Pharm, Inc. (068760.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩44,200.00 with +1.73% on the session and ₩1.96T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 48.44, gross margin 29.8%, and operating margin 10.5%.
Valuation
P/E (TTM)
48.44
PEG
—
P/B
4.53
P/S
3.52
EV/EBITDA
19.16
DCF Value
—
FCF Yield
2.7%
Div Yield
0.5%
Margins & Returns
Gross Margin
29.8%
Operating Margin
10.5%
Net Margin
7.2%
ROE
9.4%
ROA
5.2%
ROIC
7.3%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
KR
Celltrion Pharm Inc. operates as a South Korean pharmaceutical firm, specializing in the creation and distribution of biosimilar medications and over-the-counter (OTC) drugs. Its extensive product portfolio spans a multitude of therapeutic categories, encompassing treatments for conditions related to liver health, inflammation, allergies, respiratory and cardiovascular systems, digestion, hormonal and metabolic disorders, infectious diseases, immune responses, oncology, and general nutrition. The company supplies its pharmaceutical offerings to a diverse client base, including university hospitals and local pharmacies. Established in 1976, Celltrion Pharm Inc. is based in Cheongju, South Korea.